Total Funding
7
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
220757
SynGen produces advanced cell separation tools and accessories to support regenerative medicine workflows.
Acquired by 
Thermogenesis
Chuck Novak: CFOPast Role: Curexo Technology, Chief Financial Officer
George Barry: Co-FounderPast Role: Hyatt, Dementia Care Business
About the Company
SynGen enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow,
and adipose tissue. Their products provide an important enabling platform for use in diagnostic, research, and clinical processes. Their inventions are based upon interdisciplinary fields that apply principles of engineering and life sciences to develop solutions required for regenerative medicine.
